Polymesh vs Centrifuge 2026

They solve tokenization at different layers. Polymesh is a purpose-built Layer 1 blockchain: identity, compliance, and settlement are base-layer primitives, validators are permissioned entities Polymesh describes as licensed financial firms, and the chain issues no products of its own — third-party issuers mint securities on it. Centrifuge is onchain asset-management infrastructure that runs on general-purpose EVM chains (Ethereum, Avalanche, and others), and unlike Polymesh it has an affiliated asset manager, Anemoy, that issues its own flagship funds (JTRSY, JAAA, ACRDX, SPXA) sub-advised by Janus Henderson and Apollo. So Polymesh is a neutral rail; Centrifuge is a rail plus a house-branded fund set.

Neither is built for US persons. Polymesh itself issues nothing to invest in — POLYX is a utility token, and any security issued on the chain carries that issuer's own eligibility rules. Centrifuge's flagship Anemoy funds are explicitly non-US offerings: JTRSY and JAAA are for non-US professional investors, ACRDX for non-US accredited investors, all accessed by whitelisted wallets after KYC/AML. AltStreet did not identify a US investor workflow for the Centrifuge funds. If you are a US person seeking a tokenized product you can actually hold, neither platform's own products are the answer — a US issuer like Ondo is the relevant comparison — currently its OUSG Treasury token (accredited + qualified purchaser, K-1). In July 2026 Ondo also launched US custodial tokenized equities (BlackRock's IVV ETF, Micron) under the SEC's January 2026 third-party custodial staff statement, but those tokens are not yet open to US retail (initially non-US participants; broader US access is stated to follow further regulatory alignment).

No — this is the central diligence error on both platforms. POLYX is a FINMA-classified utility token used for network fees, staking, and governance; it is not a share of Polymesh or of anything issued on it, and it has fallen roughly 94% from its 2024 peak on thin depth even as the network reported institutional adoption. CFG is a governance-only token for the Centrifuge protocol; per Centrifuge's own materials it is not a claim on any Anemoy fund's cash flows, and it is down around 50% from its own V3-era high. On both platforms, the token price tracks crypto-market sentiment, not the performance of the tokenized assets. Keep any token decision separate from any product decision.

Both report genuine institutional signals, but of different kinds. Polymesh's adoption is at the infrastructure level: permissioned node operators Polymesh describes as licensed financial entities (14 at launch, including the Gibraltar Stock Exchange), a FINMA utility-token classification, and ecosystem/custody partners such as BitGo and Zodia Custody. Centrifuge's adoption is at the product level: its affiliated Anemoy funds are sub-advised by Janus Henderson and Apollo — real TradFi managers — and JTRSY won Spark's Tokenization Grand Prix (a $200M→$400M allocation), with combined protocol TVL platform-reported around $1.64B. Polymesh shows who runs the rails; Centrifuge shows who manages the money on them.

Differently transparent, and both come with caveats. Polymesh's POLYX is a freely traded token on 25+ exchanges, so it has a real, market-tested price — but on thin depth, and aggregators disagree on its circulating supply (roughly 759M–1.3B). Centrifuge publishes per-fund NAV onchain via a public API — unusually transparent for private funds — but those funds do not trade on any exchange, so the published NAV is protocol-published from issuer/administrator accounting rather than an independently market-tested or realizable price. On the credit funds (JAAA, ACRDX) especially, treat onchain NAV as a manager's mark, not an exit price. One has a market price for a token but not its products; the other has a visible NAV for its products but no market to sell into.

Both have real but narrow regulatory footprints — neither is a US-registered investment platform. Polymesh's POLYX carries a Swiss FINMA utility-token classification (a token-category determination, not a US registration or securities license), and the chain is deployed by the Polymesh Association, a Swiss non-profit. Centrifuge is 'mixed by layer': the protocol is unregistered onchain infrastructure holding a narrow SEC transfer-agent registration, while the funds are securities issued through offshore vehicles and sub-advised by regulated TradFi managers. AltStreet's EDGAR check found no Form D for the Polymesh blockchain entity (the 'Polymath' hits are an unrelated VC — a name collision), and did not locate a public PPM/Form D for the non-US Centrifuge funds. Read 'regulated' precisely on both: it describes a specific layer, not the whole stack.

Not for Polymesh itself. Polymesh is infrastructure — it offers no investment product, custodies no securities, and takes no investor capital. The securities minted on it (for example, RedSwan's tokenized real estate) belong to third-party issuers, who are responsible for those offerings. AltStreet records no Polymesh-issued deal layer, by design. Centrifuge is the opposite: it does have products to analyze, because its affiliated Anemoy funds are house-branded offerings — four funds spanning US Treasuries (JTRSY), AAA CLO (JAAA), Apollo private credit (ACRDX), and S&P 500 (SPXA), each a distinct risk profile on shared rails.

Anemoy is Centrifuge's affiliated asset manager, and its funds are the actual products. JTRSY (tokenized US T-bills, sub-advised by Janus Henderson via Tabula) has accreted smoothly to a NAV around $1.108, with third-party trackers reporting ~$761M tokenized. JAAA (a feeder into Janus Henderson's flagship AAA CLO strategy, the same team behind its ~$21B AAA CLO ETF) sits at a NAV around $1.039. ACRDX (Apollo diversified private credit) is around $1.018, and SPXA tracks the S&P 500. All four are non-US, whitelisted, NAV-accreting, and non-trading — so the NAVs are visible onchain but not realizable on a market. The Treasury fund's accretion is the most straightforward; the private-credit and CLO NAVs should be read as manager marks.

It is a network-versus-token disconnect, and it is the clearest lesson Polymesh offers. POLYX fell from a ~$0.65 onchain peak in March 2024 (CoinGecko-reported ATH $0.75) to roughly $0.038 — market cap over the trailing year alone dropped from about $199M to $48M — even as the network reported institutional adoption and advanced its Confidential Assets work. POLYX is a utility token on a thin market with uncapped, inflationary staking-reward supply; infrastructure adoption does not mechanically accrue to it. Centrifuge's CFG shows the same pattern in a different form: governance-only, down ~50% from its V3 high, disconnected from fund performance. On both, do not proxy the network's health through the token.

It depends on which side of the tokenization stack you are on. If you are an issuer, transfer agent, or institution that needs compliance and identity enforced at the protocol layer for your own regulated assets, Polymesh is the purpose-built rail. If you are a non-US professional or accredited investor who wants onchain, NAV-transparent access to an institutional strategy (Treasuries, AAA CLO, Apollo credit, or the S&P 500) and can accept mint/redeem illiquidity, a specific Centrifuge/Anemoy fund is the relevant product. If you are a US retail investor looking for something to buy, neither platform's own products fit — and neither token is a substitute for that exposure. Decide issuer-rail versus investor-fund first; the rest follows.